ARTICLE | Company News
Bioventix, CardiNor deal
February 8, 2016 8:00 AM UTC
Bioventix will develop and provide antibodies for CardiNor’s Secretoneurin in vitro diagnostic (IVD) test. Secretoneurin is a neuropeptide shown to be an independent risk marker of cardiovascular dise...